Neogen Chemicals Limited (NSE:NEOGEN)
India
· Delayed Price · Currency is INR 1,603.10
-3.20 (-0.20%)
Apr 24, 2025, 1:30 PM IST
Neogen Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 7,744 | 6,907 | 6,862 | 4,873 | 3,364 | 3,061 | Upgrade
|
| Revenue Growth (YoY) | 11.43% | 0.65% | 40.83% | 44.84% | 9.89% | 28.05% | Upgrade
|
| Cost of Revenue | 4,327 | 3,876 | 3,940 | 2,750 | 1,976 | 1,841 | Upgrade
|
| Gross Profit | 3,417 | 3,031 | 2,922 | 2,123 | 1,388 | 1,220 | Upgrade
|
| Selling, General & Admin | 652.8 | 659.9 | 499.6 | 334.1 | 208.6 | 200.35 | Upgrade
|
| Other Operating Expenses | 1,408 | 1,272 | 1,307 | 924.4 | 537.2 | 440.95 | Upgrade
|
| Operating Expenses | 2,328 | 2,159 | 1,967 | 1,374 | 813.2 | 692.14 | Upgrade
|
| Operating Income | 1,088 | 871.8 | 954.2 | 749 | 574.6 | 528.11 | Upgrade
|
| Interest Expense | -414.1 | -377.8 | -237 | -178 | -129.3 | -109.57 | Upgrade
|
| Interest & Investment Income | 74.1 | 74.1 | 38.3 | 6 | 1.2 | 0.98 | Upgrade
|
| Earnings From Equity Investments | 1.7 | 1.8 | 1 | 1.8 | 3.8 | 1.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -60.6 | -42.2 | -46.2 | -12 | -8.2 | -9.67 | Upgrade
|
| EBT Excluding Unusual Items | 689.5 | 527.7 | 710.3 | 566.8 | 442.1 | 410.97 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 3.9 | - | - | Upgrade
|
| Pretax Income | 689.5 | 527.7 | 710.3 | 570.7 | 442.1 | 410.97 | Upgrade
|
| Income Tax Expense | 196 | 171.2 | 210.6 | 124.4 | 128.8 | 124.4 | Upgrade
|
| Net Income | 493.5 | 356.5 | 499.7 | 446.3 | 313.3 | 286.57 | Upgrade
|
| Net Income to Common | 493.5 | 356.5 | 499.7 | 446.3 | 313.3 | 286.57 | Upgrade
|
| Net Income Growth | 49.36% | -28.66% | 11.96% | 42.45% | 9.33% | 36.80% | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 25 | 25 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 4.77% | 2.41% | - | 6.88% | -0.00% | 16.22% | Upgrade
|
| EPS (Basic) | 18.71 | 13.96 | 20.04 | 17.90 | 13.43 | 12.28 | Upgrade
|
| EPS (Diluted) | 18.71 | 13.96 | 20.03 | 17.90 | 13.43 | 12.28 | Upgrade
|
| EPS Growth | 42.63% | -30.31% | 11.93% | 33.28% | 9.34% | 17.74% | Upgrade
|
| Free Cash Flow | - | -3,319 | -1,328 | -1,689 | -514.5 | -631.72 | Upgrade
|
| Free Cash Flow Per Share | - | -129.96 | -53.27 | -67.71 | -22.05 | -27.07 | Upgrade
|
| Dividend Per Share | - | 2.000 | 3.000 | 2.750 | 2.250 | 2.000 | Upgrade
|
| Dividend Growth | - | -33.33% | 9.09% | 22.22% | 12.50% | 33.33% | Upgrade
|
| Gross Margin | 44.12% | 43.88% | 42.58% | 43.57% | 41.25% | 39.86% | Upgrade
|
| Operating Margin | 14.06% | 12.62% | 13.91% | 15.37% | 17.08% | 17.25% | Upgrade
|
| Profit Margin | 6.37% | 5.16% | 7.28% | 9.16% | 9.31% | 9.36% | Upgrade
|
| Free Cash Flow Margin | - | -48.06% | -19.36% | -34.66% | -15.29% | -20.64% | Upgrade
|
| EBITDA | 1,302 | 1,054 | 1,094 | 848.6 | 626.3 | 566.21 | Upgrade
|
| EBITDA Margin | 16.81% | 15.26% | 15.95% | 17.42% | 18.62% | 18.50% | Upgrade
|
| D&A For EBITDA | 213.25 | 181.9 | 140.1 | 99.6 | 51.7 | 38.1 | Upgrade
|
| EBIT | 1,088 | 871.8 | 954.2 | 749 | 574.6 | 528.11 | Upgrade
|
| EBIT Margin | 14.06% | 12.62% | 13.91% | 15.37% | 17.08% | 17.25% | Upgrade
|
| Effective Tax Rate | 28.43% | 32.44% | 29.65% | 21.80% | 29.13% | 30.27% | Upgrade
|
| Revenue as Reported | 7,800 | 6,981 | 6,906 | 4,883 | 3,366 | 3,062 | Upgrade
|
Updated Feb 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.